Wang et al. also indicated the protection role of IL-32 in lung cancer by detecting the almost 2.5 times lower mRNA expression of IL-32 rs12934561 polymorphism in patients' serum compared to healthy controls [34]. Here, IL32 is linked to lung carcinoma.